Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications

buir.contributor.authorErtaş, Yavuz Nuri
buir.contributor.orcidErtaş, Yavuz Nuri|0000-0002-6791-7484
dc.citation.epage36en_US
dc.citation.spage1en_US
dc.contributor.authorJan, N.
dc.contributor.authorMadni, A.
dc.contributor.authorKhan, S.
dc.contributor.authorShah, H.
dc.contributor.authorAkram, F.
dc.contributor.authorKhan, A.
dc.contributor.authorErtas, D.
dc.contributor.authorBostanudin, M. F.
dc.contributor.authorContag, C. H.
dc.contributor.authorAshammakhi, N.
dc.contributor.authorErtaş, Yavuz Nuri
dc.date.accessioned2023-02-28T13:08:34Z
dc.date.available2023-02-28T13:08:34Z
dc.date.issued2022-11-02
dc.departmentInstitute of Materials Science and Nanotechnology (UNAM)en_US
dc.description.abstractPoly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) are commonly used for drug delivery because of their favored biocompatibility and suitability for sustained and controlled drug release. To prolong NP circulation time, enable target-specific drug delivery and overcome physiological barriers, NPs camouflaged in cell membranes have been developed and evaluated to improve drug delivery. Here, we discuss recent advances in cell membrane-coated PLGA NPs, their preparation methods, and their application to cancer therapy, management of inflammation, treatment of cardiovascular disease and control of infection. We address the current challenges and highlight future research directions needed for effective use of cell membrane-camouflaged NPsen_US
dc.description.provenanceSubmitted by Ezgi Uğurlu (ezgi.ugurlu@bilkent.edu.tr) on 2023-02-28T13:08:34Z No. of bitstreams: 1 Biomimetic_cell_membrane-coated_poly(lactic-co-glycolic_acid)_nanoparticles_for_biomedical_applications.pdf: 32008086 bytes, checksum: a707ffc397ccbd6e13f071a2561e17be (MD5)en
dc.description.provenanceMade available in DSpace on 2023-02-28T13:08:34Z (GMT). No. of bitstreams: 1 Biomimetic_cell_membrane-coated_poly(lactic-co-glycolic_acid)_nanoparticles_for_biomedical_applications.pdf: 32008086 bytes, checksum: a707ffc397ccbd6e13f071a2561e17be (MD5) Previous issue date: 2022-11-02en
dc.identifier.doi10.1002/btm2.10441en_US
dc.identifier.eissn2380-6761
dc.identifier.urihttp://hdl.handle.net/11693/111940
dc.language.isoEnglishen_US
dc.publisherJohn Wiley & Sons, Inc.en_US
dc.relation.isversionofhttps://dx.doi.org/10.1002/btm2.10441en_US
dc.source.titleBioengineering & Translational Medicineen_US
dc.subjectBiodegradableen_US
dc.subjectBiomimeticen_US
dc.subjectCell-membraneen_US
dc.subjectDrug deliveryen_US
dc.subjectPLGAen_US
dc.subjectTargeted deliveryen_US
dc.titleBiomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applicationsen_US
dc.typeReviewen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Biomimetic_cell_membrane-coated_poly(lactic-co-glycolic_acid)_nanoparticles_for_biomedical_applications.pdf
Size:
30.53 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description: